Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Mei-Chih Liang"'
Autor:
Kwok-Kin Wong, Lynda Chin, Bruce E. Johnson, Pasi A. Jänne, Levi A. Garraway, Roman K. Thomas, Roderick T. Bronson, Robert Padera, Lucian R. Chirieac, Ruqayyah Al-Hashem, Yanping Sun, Mitchell Albert, Liang Chen, Kate McNamara, Sara Zaghlul, Mei-Chih Liang, Danan Li, Samanthi A. Perera, Zhenxiong Wang, Hongbin Ji
Supplementary Figure 2 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452539fd69c52c42a27e576f6257d8e2
https://doi.org/10.1158/0008-5472.22367991.v1
https://doi.org/10.1158/0008-5472.22367991.v1
Autor:
Kwok-Kin Wong, Lynda Chin, Bruce E. Johnson, Pasi A. Jänne, Levi A. Garraway, Roman K. Thomas, Roderick T. Bronson, Robert Padera, Lucian R. Chirieac, Ruqayyah Al-Hashem, Yanping Sun, Mitchell Albert, Liang Chen, Kate McNamara, Sara Zaghlul, Mei-Chih Liang, Danan Li, Samanthi A. Perera, Zhenxiong Wang, Hongbin Ji
Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0a283c59ce7e1f21f2056e05afd316
https://doi.org/10.1158/0008-5472.22367982
https://doi.org/10.1158/0008-5472.22367982
Autor:
Kwok-Kin Wong, Jeffrey A. Engelman, Ulrik B. Nielsen, Youngchul Song, Aaron Fulgham, Lin Nie, Zandra Walton, Emily Pace, Olga Burenkova, Matthew Onsum, Katherine Crosby, Mei-Chih Liang, Danan Li, Anthony C. Faber, Birgit Schoeberl
Supplementary Methods, Figures 1-8, Table 1 from An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156ef0fc867f4fa59fe97a8529ab0e55
https://doi.org/10.1158/0008-5472.22386953
https://doi.org/10.1158/0008-5472.22386953
Autor:
Kwok-Kin Wong, Lynda Chin, Bruce E. Johnson, Pasi A. Jänne, Levi A. Garraway, Roman K. Thomas, Roderick T. Bronson, Robert Padera, Lucian R. Chirieac, Ruqayyah Al-Hashem, Yanping Sun, Mitchell Albert, Liang Chen, Kate McNamara, Sara Zaghlul, Mei-Chih Liang, Danan Li, Samanthi A. Perera, Zhenxiong Wang, Hongbin Ji
Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749d76776248e8968677512086153327
https://doi.org/10.1158/0008-5472.22367988.v1
https://doi.org/10.1158/0008-5472.22367988.v1
Autor:
Kwok-Kin Wong, Lynda Chin, Bruce E. Johnson, Pasi A. Jänne, Levi A. Garraway, Roman K. Thomas, Roderick T. Bronson, Robert Padera, Lucian R. Chirieac, Ruqayyah Al-Hashem, Yanping Sun, Mitchell Albert, Liang Chen, Kate McNamara, Sara Zaghlul, Mei-Chih Liang, Danan Li, Samanthi A. Perera, Zhenxiong Wang, Hongbin Ji
Mutations in the BRAF and KRAS genes occur in ∼1% to 2% and 20% to 30% of non–small-cell lung cancer patients, respectively, suggesting that the mitogen-activated protein kinase (MAPK) pathway is preferentially activated in lung cancers. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa21c06bbab8111e68ca1c70488665b5
https://doi.org/10.1158/0008-5472.c.6495762
https://doi.org/10.1158/0008-5472.c.6495762
Autor:
Kwok-Kin Wong, Lynda Chin, Bruce E. Johnson, Pasi A. Jänne, Levi A. Garraway, Roman K. Thomas, Roderick T. Bronson, Robert Padera, Lucian R. Chirieac, Ruqayyah Al-Hashem, Yanping Sun, Mitchell Albert, Liang Chen, Kate McNamara, Sara Zaghlul, Mei-Chih Liang, Danan Li, Samanthi A. Perera, Zhenxiong Wang, Hongbin Ji
Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a77ab244aa3ac1147538aa7655da4754
https://doi.org/10.1158/0008-5472.22367994
https://doi.org/10.1158/0008-5472.22367994
Autor:
Yu-Chi Chan, Mei-Chih Liang, Chinpiao Chen, Chien-Jen Chang, Ya-Hui Wu, Pei-Ying Pan, Rou-Hsin Wang, Chih-Man Yang, Jinn-Moon Yang, Ya-Ping Hsu, Kuang-Kai Liu, Chien-Hung Chen, Su-Pei Wang, Kwok-Kin Wong, Jui-I Chao
Publikováno v:
Biochemical Pharmacology. 193:114792
Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are currently used therapy for non-small cell lung cancer (NSCLC) patients; however, drug resistance during cancer treatment is a critical problem. Survivin is an anti-apoptos
Autor:
Chung-Ming Sun, Pei Hua Tsai, Mei-Chih Liang, Tushar Ulhas Thikekar, Vijaykumar Paike, Tsai Wen Chung, Fu Yuan Lo, Yi Tzu Hung
Publikováno v:
ACS Combinatorial Science. 17:442-451
A sequential single-flask multicomponent reactions is highly effective for the synthesis of 1,2-dihydroisoquinolines through amidealkylation from intermediate N-acylisoquinolinium salts under mild conditions. N-Acylisoquinolinium ions and trichlorome
Autor:
Mei-Chih Liang, Yenshou Lin, Chih Han Lee, Han Jung Tsai, Rih Sheng Huang, Yan Qing Song, Hsiu Mei Hsieh-Li, Tian Syuan Lin
Publikováno v:
Journal of Alzheimer's disease : JAD. 56(3)
The presence of amyloid-β (Aβ) plaque and tau protein hyperphosphorylation in brain tissue is the pathological hallmark of Alzheimer's disease (AD). At least some Aβ neurotoxicity is caused by the presence of excess glutamate that has been induced
Autor:
Chun-Hao Pan, Jen-Chung Ko, Ming-Shuo Lee, Sheng-Kai Liang, Mei-Chih Liang, B-Chen Wen, Ying-Fang Chang
Publikováno v:
BMC Cancer
Background Vorinostat, a histone deacetylase (HDAC) inhibitor, is a promising agent for cancer therapy. Combining vorinostat with cisplatin may relax the chromatin structure and facilitate the accessibility of cisplatin, thus enhancing its cytotoxici